2 days Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street InteractiveZacks

Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive have been highlighted in this Screen of The Week article.

Pharmaceuticals · Synchrony Financial (SYF)

17 hours ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?Zacks X

17 hours ARS Pharmaceuticals: Demand Curve Is Key UnknownSeeking Alpha X

18 hours Acurx to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbookCNBC X

20 hours Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?Zacks X

2 days Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

2 days Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here’s What You Should KnowZacks X

2 days Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript)Seeking Alpha X

2 days Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3Insider Monkey X

2 days How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%Zacks X

2 days After Golden Cross, Milestone Pharmaceuticals (MIST)’s Technical Outlook is BrightZacks X

2 days Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?Zacks X

2 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowZacks X

2 days Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” InvestmentInsider Monkey X

2 days NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call TranscriptSeeking Alpha X

3 days Elite Pharmaceuticals’ Stock Up Despite Q2 Earnings DeclineZacks X

3 days Jazz Pharmaceuticals: High Uncertainty, Low RiskSeeking Alpha X

3 days Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here’s is How to TradeZacks X

3 days Here’s Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 WeeksZacks X

3 days ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis StudyZacks X

3 days What Makes Eton Pharmaceuticals (ETON) a Good Fit for ‘Trend Investing’Zacks X

3 days Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?Insider Monkey X

5 days Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call TranscriptSeeking Alpha X

6 days Synchrony (SYF) Up 14.4% Since Last Earnings Report: Can It Continue?Zacks X

6 days Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

6 days Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call TranscriptThe Motley Fool X

6 days Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call TranscriptSeeking Alpha X

6 days Inovio Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

7 days 60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue EstimatesZacks X

7 days Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary GoalZacks X

7 days 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

7 days New Strong Buy Stocks for November 14thZacks X

1 week EyePoint Pharmaceuticals: Low Price And Good Data Create An OpportunitySeeking Alpha X

1 week Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week X4 Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

1 week X4 Pharmaceuticals, Inc. (XFOR) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue EstimatesZacks X

1 week Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Tops Revenue EstimatesZacks X

1 week Jazz (JAZZ) Upgraded to Buy: Here’s WhyZacks X

1 week Acurx Pharmaceuticals, Inc. (ACXP) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week JAZZ or CTLT: Which Is the Better Value Stock Right Now?Zacks X

1 week Xenon Q3 Loss Narrower Than Expected, Pipeline Development in FocusZacks X

1 week Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025?Insider Monkey X

1 week Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High?Zacks X

1 week Wall Street Analysts See a 175.07% Upside in EyePoint Pharmaceuticals (EYPT): Can the Stock Really Move This High?Zacks X

1 week Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation OpportunityThe Motley Fool X

1 week Corvus Pharmaceuticals, Inc. (CRVS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Lexicon Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

1 week Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

More news +